Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions.

Harmanjeet HarmanjeetHet JaniSyed Tabish R ZaidiTroy WanandyRonald L CastelinoKamal SudGregory M PetersonRahul P Patel

Published in: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (2020)

These results provide a platform for clinical studies to determine the safety and therapeutic efficacy of intraperitoneal C/T for the treatment of PDAP caused by resistant Pseudomonas species.

Keyphrases

peritoneal dialysis
end stage renal disease
chronic kidney disease
gram negative
high throughput
escherichia coli
biofilm formation
combination therapy
pseudomonas aeruginosa
single cell